Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000983:Antipyrine / Q000097:blood / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001577:Benzophenones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D011422:Propionates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001577:Benzophenones; D011422:Propionates; D000983:Antipyrine